Novavax
NVAX
#5786
Rank
C$1.52 B
Marketcap
C$9.39
Share price
-1.88%
Change (1 day)
-26.81%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): C$0.54 Billion

According to Novavax's latest financial reports the company's current earnings are C$1.02 Billion. In 2024 the company made an earning of -C$0.22 Billion, an increase over its 2023 earnings that were of -C$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.54 B-349.14%
2024 -C$0.22 Billion-70.39%
2023 -C$0.74 Billion-16.59%
2022 -C$0.88 Billion-62.58%
2021 -C$2.35 Billion320.54%
2020 -C$0.56 Billion234.22%
2019 -C$0.17 Billion-30.17%
2018 -C$0.24 Billion1.69%
2017 -C$0.24 Billion-36.44%
2016 -C$0.37 Billion70.4%
2015 -C$0.22 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$71.76 Million81.9%
2012 -C$39.45 Million50.33%
2011 -C$26.25 Million
2009 -C$51.79 Million8.8%
2008 -C$47.6 Million18.01%
2007 -C$40.34 Million18.33%
2006 -C$34.09 Million168.31%
2005 -C$12.71 Million-62.51%
2004 -C$33.89 Million52.4%
2003 -C$22.24 Million-28.21%
2002 -C$30.98 Million
2000 -C$17.66 Million177%
1999 -C$6.38 Million-11.54%
1998 -C$7.21 Million10.64%
1997 -C$6.52 Million-9.62%
1996 -C$7.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
C$28.62 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.35 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$9.17 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.13 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$16.41 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.74 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-C$13.12 Million-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.91 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.36 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA